🔎 Trials Near Me

Home › COPD › Maine › Bangor

COPD clinical trials in Bangor, ME

3 studies for COPD are looking for participants at sites in and around Bangor (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

RecruitingPhase 2/3
  • Paul A. Shapero, MD, PA, Bangor
Ages 35 to 80 · All sexes · Updated Aug 31, 2026 · NCT07363694

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

RecruitingPhase 3
  • GSK Investigational Site, Bangor
Ages 40 to 75 · All sexes · Updated Jul 28, 2026 · NCT07177339

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

RecruitingPhase 3
  • GSK Investigational Site, Bangor
Ages 40 to 80 · All sexes · Updated Apr 9, 2026 · NCT06961214

About COPD

COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.

More about COPD on MedlinePlus

COPD trials in other cities

Other studies in Bangor

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.